Jeffrey A. Rona - 26 Feb 2025 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Reporting relationship: CBFO
Issuer ticker: OVID
Reported as of: 26 Feb 2025
Net transaction value: -$2,185
SEC form: 4
Accepted by SEC: 28 Feb 2025, 16:15:08 UTC
Prior SEC filing: 24 Feb 2025
Next SEC filing: 02 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jason Minio, Attorney-in-Fact

Key filing fact

Jeffrey A. Rona filed Form 4 for Ovid Therapeutics Inc. (OVID) on 28 Feb 2025.

Key facts

This page summarizes Jeffrey A. Rona's Form 4 filing for Ovid Therapeutics Inc. (OVID).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Feb 2025, 16:15.

Change

Previous filing in this sequence was filed on 24 Feb 2025.
Current net transaction value: -$2,185.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OVID transaction

Common Stock

Sale

Transaction value: $2,185
Shares: -3,902
Change %: -5.4%
Price: $0.5600
Shares after: 67,973
Date: 26 Feb 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.